ALA also enhances insulin sensitivity and shows the potential in preventing microvascular complications [23,24] and ameliorating comorbidities like obesity, hypertension, and dyslipidemia [25]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.